Market Overview:
The global in vitro diagnostics (IVD) products and test market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market is segmented by type, application, and region. The type segment includes general chemistries, critical care, urinalysis, analyzers blood gases, workstations, and others. The application segment includes molecular diagnostics, clinical chemistry diabetes and glucose testing immunochemistry hematology others). The region segments include North America Latin America Europe Asia Pacific Middle East & Africa). Some of the factors that are driving the growth of this market are the increasing incidence of diseases; growing demand for early diagnosis; technological advancements in IVD products; rising awareness about preventive healthcare; and increase in funding for research on novel diagnostic tests.
 Products and Test Industry Outlook.svg)
Product Definition:
An in vitro diagnostic (IVD) product is a product that is used to diagnose a disease or condition. IVD products include tests, reagents, and kits. The use of IVD products is critical for the diagnosis of diseases and conditions.
General Chemistries:
General chemistry is the study of the chemical composition of matter. It includes physical and chemical properties, structure, bonding, reactions, and changes in state that occur due to different substances. The field has witnessed tremendous growth over the past few years owing to technological advancements such as high-performance liquid chromatography (HPLC) systems with better resolution for separating chiral compounds and mass spectrometry which can identify a wide range of molecules based on their molecular weight or ionization.
Critical Care:
Critical care is a set of procedures and therapies used to treat life-threatening conditions. The IVD products and test market are expected to grow at a rapid pace over the forecast period owing to increasing demand for point of care testing (POC) devices, rising prevalence of chronic diseases such as cancer, diabetes mellitus, cardiovascular disorders & respiratory diseases among other factors.
Application Insights:
The molecular diagnostics segment dominated the global in vitro diagnostics (IVD) products and test market by application, accounting for a revenue share of over 30.0% in 2017. This is owing to the rising demand for highly specific and sensitive tests that can identify single molecule with high accuracy, specificity, and sensitivity. The growing prevalence of chronic diseases such as cancer & autoimmune disorders that require highly accurate diagnosis at an early stage is also expected to contribute significantly towards growth during the forecast period.
Clinical chemistry is anticipated to grow at a lucrative rate during the forecast period due to its wide applications across various diagnostic areas such as drug testing, disease states detection, electrolyte & acid/base balance assessment among others which have led it being one of the most widely used segments within IVD market space worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of advanced products. Moreover, increasing government initiatives for disease prevention and control is also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to improving healthcare infrastructure coupled with rising awareness about IVD testing among people in this region as compared to other regions.
Moreover, supportive regulations such as favorable reimbursement policies are further anticipated propel regional market growth over the forecast period Latin America has a wide population base suffering from chronic diseases that require regular monitoring & testing at various clinical laboratories including hematology&laboratory diagnostics; immunochemistry; urinalysis; critical care medicine analyzers blood gas workstations others).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in IVD products and tests
- Growing number of public and private sector initiatives to promote use of IVD products and tests
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Diagnostics (IVD) Products and Test Market Research Report
By Type
General Chemistries, Critical Care, Urinalysis, Analyzers Blood Gases, Workstations, Others
By Application
Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing, Immunochemistry, Hematology, Others
By Companies
Abbott Laboratories(US), Becton Dickinson Company(US), bioMerieux SA(France), F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare(Germany), Alere Inc(US), Beckman Coulter, Inc.(US), Bio-Rad Laboratories(US), Hologic(US), Ortho Clinical Diagnostics(US), Roche Diagnostics(US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Diagnostics (IVD) Products and Test Market Report Segments:
The global In Vitro Diagnostics (IVD) Products and Test market is segmented on the basis of:
Types
General Chemistries, Critical Care, Urinalysis, Analyzers Blood Gases, Workstations, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing, Immunochemistry, Hematology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories(US)
- Becton Dickinson Company(US)
- bioMerieux SA(France)
- F. Hoffmann-La Roche Ltd.(Switzerland)
- Siemens Healthcare(Germany)
- Alere Inc(US)
- Beckman Coulter, Inc.(US)
- Bio-Rad Laboratories(US)
- Hologic(US)
- Ortho Clinical Diagnostics(US)
- Roche Diagnostics(US)
 Products and Test Market Overview.svg)
Highlights of The In Vitro Diagnostics (IVD) Products and Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- General Chemistries
- Critical Care
- Urinalysis
- Analyzers Blood Gases
- Workstations
- Others
- By Application:
- Molecular Diagnostics
- Clinical Chemistry
- Diabetes and Glucose Testing
- Immunochemistry
- Hematology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Diagnostics (IVD) Products and Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Products and Test Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD products and tests are medical devices that help diagnose and treat diseases in a controlled environment. IVD products can be used to test for a variety of conditions, including cancer, heart disease, diabetes, and more.
Some of the major companies in the in vitro diagnostics (ivd) products and test market are Abbott Laboratories(US), Becton Dickinson Company(US), bioMerieux SA(France), F. Hoffmann-La Roche Ltd.(Switzerland), Siemens Healthcare(Germany), Alere Inc(US), Beckman Coulter, Inc.(US), Bio-Rad Laboratories(US), Hologic(US), Ortho Clinical Diagnostics(US), Roche Diagnostics(US).
The in vitro diagnostics (ivd) products and test market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics (IVD) Products and Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In Vitro Diagnostics (IVD) Products and Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In Vitro Diagnostics (IVD) Products and Test Market - Supply Chain
4.5. Global In Vitro Diagnostics (IVD) Products and Test Market Forecast
4.5.1. In Vitro Diagnostics (IVD) Products and Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In Vitro Diagnostics (IVD) Products and Test Market Size (000 Units) and Y-o-Y Growth
4.5.3. In Vitro Diagnostics (IVD) Products and Test Market Absolute $ Opportunity
5. Global In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Type
5.3.1. General Chemistries
5.3.2. Critical Care
5.3.3. Urinalysis
5.3.4. Analyzers Blood Gases
5.3.5. Workstations
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
6.3.1. Molecular Diagnostics
6.3.2. Clinical Chemistry
6.3.3. Diabetes and Glucose Testing
6.3.4. Immunochemistry
6.3.5. Hematology
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global In Vitro Diagnostics (IVD) Products and Test Demand Share Forecast, 2019-2026
9. North America In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
9.4.1. Molecular Diagnostics
9.4.2. Clinical Chemistry
9.4.3. Diabetes and Glucose Testing
9.4.4. Immunochemistry
9.4.5. Hematology
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Type
9.7.1. General Chemistries
9.7.2. Critical Care
9.7.3. Urinalysis
9.7.4. Analyzers Blood Gases
9.7.5. Workstations
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America In Vitro Diagnostics (IVD) Products and Test Demand Share Forecast, 2019-2026
10. Latin America In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
10.4.1. Molecular Diagnostics
10.4.2. Clinical Chemistry
10.4.3. Diabetes and Glucose Testing
10.4.4. Immunochemistry
10.4.5. Hematology
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Type
10.7.1. General Chemistries
10.7.2. Critical Care
10.7.3. Urinalysis
10.7.4. Analyzers Blood Gases
10.7.5. Workstations
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America In Vitro Diagnostics (IVD) Products and Test Demand Share Forecast, 2019-2026
11. Europe In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
11.4.1. Molecular Diagnostics
11.4.2. Clinical Chemistry
11.4.3. Diabetes and Glucose Testing
11.4.4. Immunochemistry
11.4.5. Hematology
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe In Vitro Diagnostis (IVD) Products and Test Market Size and Volume Forecast by Type
11.7.1. General Chemistries
11.7.2. Critical Care
11.7.3. Urinalysis
11.7.4. Analyzers Blood Gases
11.7.5. Workstations
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe In Vitro Diagnostics (IVD) Products and Test Demand Share, 2019-2026
12. Asia Pacific In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
12.4.1. Molecular Diagnostics
12.4.2. Clinical Chemistry
12.4.3. Diabetes and Glucose Testing
12.4.4. Immunochemistry
12.4.5. Hematology
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Type
12.7.1. General Chemistries
12.7.2. Critical Care
12.7.3. Urinalysis
12.7.4. Analyzers Blood Gases
12.7.5. Workstations
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific In Vitro Diagnostics (IVD) Products and Test Demand Share, 2019-2026
13. Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Application
13.4.1. Molecular Diagnostics
13.4.2. Clinical Chemistry
13.4.3. Diabetes and Glucose Testing
13.4.4. Immunochemistry
13.4.5. Hematology
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size and Volume Forecast by Type
13.7.1. General Chemistries
13.7.2. Critical Care
13.7.3. Urinalysis
13.7.4. Analyzers Blood Gases
13.7.5. Workstations
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Demand Share, 2019-2026
14. Competition Landscape
14.1. Global In Vitro Diagnostics (IVD) Products and Test Market: Market Share Analysis
14.2. In Vitro Diagnostics (IVD) Products and Test Distributors and Customers
14.3. In Vitro Diagnostics (IVD) Products and Test Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories(US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Becton Dickinson Company(US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. bioMerieux SA(France)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. F. Hoffmann-La Roche Ltd.(Switzerland)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens Healthcare(Germany)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Alere Inc(US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Beckman Coulter, Inc.(US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad Laboratories(US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hologic(US)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Ortho Clinical Diagnostics(US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Roche Diagnostics(US)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
